• Toronto, Ontario, Canada

Order of Canada

• Officer of the Order of Canada

  • Awarded on: November 22, 2019
  • Invested on: October 26, 2023

  Bernard Zinman, O.C.
  Toronto, Ontario
  
  The impact of Bernard Zinman’s groundbreaking research extends far beyond the millions of Canadians living with diabetes. In recent years, he has spearheaded the evaluation of new therapies for type 2 diabetes, which have significantly reduced rates of cardiovascular complications and deaths within this segment of the population. His discoveries have resulted in major changes to treatment management guidelines worldwide. In addition to being a prolific writer, he has played a crucial role in the global recognition of the Lunenfeld-Tanenbaum Research Institute and Mount Sinai Hospital as leaders in the field.
  
  This is a promotion within the Order.

• Member of the Order of Canada

  • Awarded on: November 3, 2011
  • Invested on: May 25, 2012

  Bernard Zinman is a leader in diabetes care and research. He has advanced the development of therapies for diabetes and the prevention of its long-term complications, notably through his pivotal role in the largest and most comprehensive clinical study of type 1 diabetes. Professor of medicine at the University of Toronto, he is the director of the Leadership Sinai Centre for Diabetes at Mount Sinai Hospital, and is the senior scientist at the Samuel Lunenfield Research Institute.